Global Recombinant Human Endostatin Sales Market Report 2016

Publisher Name :
Date: 08-Sep-2016
No. of pages: 123

Notes:

Sales, means the sales volume of Recombinant Human Endostatin

Revenue, means the sales value of Recombinant Human Endostatin

This report studies sales (consumption) of Recombinant Human Endostatin in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Pfizer

- Allergan

- Alnylam Pharmaceuticals

- Amgen

- Angstrom Pharmaceuticals

- Acceleron Pharma

- Biocon

- Bionomics

- CASI Pharmaceuticals

- Celgene Corporation

- Enzon Pharmaceuticals

- Five Prime Therapeutics

- Fujifilm Kyowa Kirin Biologics

- Genentech

- Genexine

- Hetero Drugs

- ImClone Systems

- Intas Pharmaceuticals

- Kyowa Hakko Kirin

- Levolta Pharmaceuticals

- Mabtech

- Marsala Biotech

- Neumedicines

- Novartis

- Oncobiologics

- Onyx Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Recombinant Human Endostatin in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Recombinant Human Endostatin in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Recombinant Human Endostatin Sales Market Report 2016

Table of Contents
Global Recombinant Human Endostatin Sales Market Report 2016
1 Recombinant Human Endostatin Overview
1.1 Product Overview and Scope of Recombinant Human Endostatin
1.2 Classification of Recombinant Human Endostatin
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Recombinant Human Endostatin
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Recombinant Human Endostatin Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Recombinant Human Endostatin (2011-2021)
1.5.1 Global Recombinant Human Endostatin Sales and Growth Rate (2011-2021)
1.5.2 Global Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)
2 Global Recombinant Human Endostatin Competition by Manufacturers, Type and Application
2.1 Global Recombinant Human Endostatin Market Competition by Manufacturers
2.1.1 Global Recombinant Human Endostatin Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Recombinant Human Endostatin Revenue and Share by Manufacturers (2011-2016)
2.2 Global Recombinant Human Endostatin (Volume and Value) by Type
2.2.1 Global Recombinant Human Endostatin Sales and Market Share by Type (2011-2016)
2.2.2 Global Recombinant Human Endostatin Revenue and Market Share by Type (2011-2016)
2.3 Global Recombinant Human Endostatin (Volume and Value) by Regions
2.3.1 Global Recombinant Human Endostatin Sales and Market Share by Regions (2011-2016)
2.3.2 Global Recombinant Human Endostatin Revenue and Market Share by Regions (2011-2016)
2.4 Global Recombinant Human Endostatin (Volume) by Application
3 USA Recombinant Human Endostatin (Volume, Value and Sales Price)
3.1 USA Recombinant Human Endostatin Sales and Value (2011-2016)
3.1.1 USA Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
3.1.2 USA Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
3.1.3 USA Recombinant Human Endostatin Sales Price Trend (2011-2016)
3.2 USA Recombinant Human Endostatin Sales and Market Share by Manufacturers
3.3 USA Recombinant Human Endostatin Sales and Market Share by Type
3.4 USA Recombinant Human Endostatin Sales and Market Share by Application
4 China Recombinant Human Endostatin (Volume, Value and Sales Price)
4.1 China Recombinant Human Endostatin Sales and Value (2011-2016)
4.1.1 China Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
4.1.2 China Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
4.1.3 China Recombinant Human Endostatin Sales Price Trend (2011-2016)
4.2 China Recombinant Human Endostatin Sales and Market Share by Manufacturers
4.3 China Recombinant Human Endostatin Sales and Market Share by Type
4.4 China Recombinant Human Endostatin Sales and Market Share by Application
5 Europe Recombinant Human Endostatin (Volume, Value and Sales Price)
5.1 Europe Recombinant Human Endostatin Sales and Value (2011-2016)
5.1.1 Europe Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
5.1.2 Europe Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
5.1.3 Europe Recombinant Human Endostatin Sales Price Trend (2011-2016)
5.2 Europe Recombinant Human Endostatin Sales and Market Share by Manufacturers
5.3 Europe Recombinant Human Endostatin Sales and Market Share by Type
5.4 Europe Recombinant Human Endostatin Sales and Market Share by Application
6 Japan Recombinant Human Endostatin (Volume, Value and Sales Price)
6.1 Japan Recombinant Human Endostatin Sales and Value (2011-2016)
6.1.1 Japan Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
6.1.2 Japan Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
6.1.3 Japan Recombinant Human Endostatin Sales Price Trend (2011-2016)
6.2 Japan Recombinant Human Endostatin Sales and Market Share by Manufacturers
6.3 Japan Recombinant Human Endostatin Sales and Market Share by Type
6.4 Japan Recombinant Human Endostatin Sales and Market Share by Application
7 India Recombinant Human Endostatin (Volume, Value and Sales Price)
7.1 India Recombinant Human Endostatin Sales and Value (2011-2016)
7.1.1 India Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
7.1.2 India Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
7.1.3 India Recombinant Human Endostatin Sales Price Trend (2011-2016)
7.2 India Recombinant Human Endostatin Sales and Market Share by Manufacturers
7.3 India Recombinant Human Endostatin Sales and Market Share by Type
7.4 India Recombinant Human Endostatin Sales and Market Share by Application
8 Southeast Asia Recombinant Human Endostatin (Volume, Value and Sales Price)
8.1 Southeast Asia Recombinant Human Endostatin Sales and Value (2011-2016)
8.1.1 Southeast Asia Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Recombinant Human Endostatin Sales Price Trend (2011-2016)
8.2 Southeast Asia Recombinant Human Endostatin Sales and Market Share by Manufacturers
8.3 Southeast Asia Recombinant Human Endostatin Sales and Market Share by Type
8.4 Southeast Asia Recombinant Human Endostatin Sales and Market Share by Application
9 Global Recombinant Human Endostatin Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Recombinant Human Endostatin Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Pfizer Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Allergan
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 123 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Allergan Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Alnylam Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 145 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Alnylam Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Amgen
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Aug Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Amgen Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Angstrom Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Angstrom Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Acceleron Pharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Acceleron Pharma Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Biocon
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharma & Healthcare Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Biocon Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Bionomics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 Bionomics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 CASI Pharmaceuticals
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 CASI Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 Celgene Corporation
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 Celgene Corporation Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Enzon Pharmaceuticals
9.12 Five Prime Therapeutics
9.13 Fujifilm Kyowa Kirin Biologics
9.14 Genentech
9.15 Genexine
9.16 Hetero Drugs
9.17 ImClone Systems
9.18 Intas Pharmaceuticals
9.19 Kyowa Hakko Kirin
9.20 Levolta Pharmaceuticals
9.21 Mabtech
9.22 Marsala Biotech
9.23 Neumedicines
9.24 Novartis
9.25 Oncobiologics
9.26 Onyx Pharmaceuticals
10 Recombinant Human Endostatin Maufacturing Cost Analysis
10.1 Recombinant Human Endostatin Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Recombinant Human Endostatin
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Recombinant Human Endostatin Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Recombinant Human Endostatin Market Forecast (2016-2021)
14.1 Global Recombinant Human Endostatin Sales, Revenue Forecast (2016-2021)
14.2 Global Recombinant Human Endostatin Sales Forecast by Regions (2016-2021)
14.3 Global Recombinant Human Endostatin Sales Forecast by Type (2016-2021)
14.4 Global Recombinant Human Endostatin Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Recombinant Human Endostatin
Table Classification of Recombinant Human Endostatin
Figure Global Sales Market Share of Recombinant Human Endostatin by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Recombinant Human Endostatin
Figure Global Sales Market Share of Recombinant Human Endostatin by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)
Figure China Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)
Figure Europe Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)
Figure Japan Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)
Figure India Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)
Figure Global Recombinant Human Endostatin Sales and Growth Rate (2011-2021)
Figure Global Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)
Table Global Recombinant Human Endostatin Sales of Key Manufacturers (2011-2016)
Table Global Recombinant Human Endostatin Sales Share by Manufacturers (2011-2016)
Figure 2015 Recombinant Human Endostatin Sales Share by Manufacturers
Figure 2016 Recombinant Human Endostatin Sales Share by Manufacturers
Table Global Recombinant Human Endostatin Revenue by Manufacturers (2011-2016)
Table Global Recombinant Human Endostatin Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Recombinant Human Endostatin Revenue Share by Manufacturers
Table 2016 Global Recombinant Human Endostatin Revenue Share by Manufacturers
Table Global Recombinant Human Endostatin Sales and Market Share by Type (2011-2016)
Table Global Recombinant Human Endostatin Sales Share by Type (2011-2016)
Figure Sales Market Share of Recombinant Human Endostatin by Type (2011-2016)
Figure Global Recombinant Human Endostatin Sales Growth Rate by Type (2011-2016)
Table Global Recombinant Human Endostatin Revenue and Market Share by Type (2011-2016)
Table Global Recombinant Human Endostatin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Recombinant Human Endostatin by Type (2011-2016)
Figure Global Recombinant Human Endostatin Revenue Growth Rate by Type (2011-2016)
Table Global Recombinant Human Endostatin Sales and Market Share by Regions (2011-2016)
Table Global Recombinant Human Endostatin Sales Share by Regions (2011-2016)
Figure Sales Market Share of Recombinant Human Endostatin by Regions (2011-2016)
Figure Global Recombinant Human Endostatin Sales Growth Rate by Regions (2011-2016)
Table Global Recombinant Human Endostatin Revenue and Market Share by Regions (2011-2016)
Table Global Recombinant Human Endostatin Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Recombinant Human Endostatin by Regions (2011-2016)
Figure Global Recombinant Human Endostatin Revenue Growth Rate by Regions (2011-2016)
Table Global Recombinant Human Endostatin Sales and Market Share by Application (2011-2016)
Table Global Recombinant Human Endostatin Sales Share by Application (2011-2016)
Figure Sales Market Share of Recombinant Human Endostatin by Application (2011-2016)
Figure Global Recombinant Human Endostatin Sales Growth Rate by Application (2011-2016)
Figure USA Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
Figure USA Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
Figure USA Recombinant Human Endostatin Sales Price Trend (2011-2016)
Table USA Recombinant Human Endostatin Sales by Manufacturers (2011-2016)
Table USA Recombinant Human Endostatin Market Share by Manufacturers (2011-2016)
Table USA Recombinant Human Endostatin Sales by Type (2011-2016)
Table USA Recombinant Human Endostatin Market Share by Type (2011-2016)
Table USA Recombinant Human Endostatin Sales by Application (2011-2016)
Table USA Recombinant Human Endostatin Market Share by Application (2011-2016)
Figure China Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
Figure China Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
Figure China Recombinant Human Endostatin Sales Price Trend (2011-2016)
Table China Recombinant Human Endostatin Sales by Manufacturers (2011-2016)
Table China Recombinant Human Endostatin Market Share by Manufacturers (2011-2016)
Table China Recombinant Human Endostatin Sales by Type (2011-2016)
Table China Recombinant Human Endostatin Market Share by Type (2011-2016)
Table China Recombinant Human Endostatin Sales by Application (2011-2016)
Table China Recombinant Human Endostatin Market Share by Application (2011-2016)
Figure Europe Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
Figure Europe Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
Figure Europe Recombinant Human Endostatin Sales Price Trend (2011-2016)
Table Europe Recombinant Human Endostatin Sales by Manufacturers (2011-2016)
Table Europe Recombinant Human Endostatin Market Share by Manufacturers (2011-2016)
Table Europe Recombinant Human Endostatin Sales by Type (2011-2016)
Table Europe Recombinant Human Endostatin Market Share by Type (2011-2016)
Table Europe Recombinant Human Endostatin Sales by Application (2011-2016)
Table Europe Recombinant Human Endostatin Market Share by Application (2011-2016)
Figure Japan Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
Figure Japan Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
Figure Japan Recombinant Human Endostatin Sales Price Trend (2011-2016)
Table Japan Recombinant Human Endostatin Sales by Manufacturers (2011-2016)
Table Japan Recombinant Human Endostatin Market Share by Manufacturers (2011-2016)
Table Japan Recombinant Human Endostatin Sales by Type (2011-2016)
Table Japan Recombinant Human Endostatin Market Share by Type (2011-2016)
Table Japan Recombinant Human Endostatin Sales by Application (2011-2016)
Table Japan Recombinant Human Endostatin Market Share by Application (2011-2016)
Figure India Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
Figure India Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
Figure India Recombinant Human Endostatin Sales Price Trend (2011-2016)
Table India Recombinant Human Endostatin Sales by Manufacturers (2011-2016)
Table India Recombinant Human Endostatin Market Share by Manufacturers (2011-2016)
Table India Recombinant Human Endostatin Sales by Type (2011-2016)
Table India Recombinant Human Endostatin Market Share by Type (2011-2016)
Table India Recombinant Human Endostatin Sales by Application (2011-2016)
Table India Recombinant Human Endostatin Market Share by Application (2011-2016)
Figure Southeast Asia Recombinant Human Endostatin Sales and Growth Rate (2011-2016)
Figure Southeast Asia Recombinant Human Endostatin Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Recombinant Human Endostatin Sales Price Trend (2011-2016)
Table Southeast Asia Recombinant Human Endostatin Sales by Manufacturers (2011-2016)
Table Southeast Asia Recombinant Human Endostatin Market Share by Manufacturers (2011-2016)
Table Southeast Asia Recombinant Human Endostatin Sales by Type (2011-2016)
Table Southeast Asia Recombinant Human Endostatin Market Share by Type (2011-2016)
Table Southeast Asia Recombinant Human Endostatin Sales by Application (2011-2016)
Table Southeast Asia Recombinant Human Endostatin Market Share by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Recombinant Human Endostatin Global Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Recombinant Human Endostatin Global Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alnylam Pharmaceuticals Recombinant Human Endostatin Global Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Recombinant Human Endostatin Global Market Share (2011-2016)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Angstrom Pharmaceuticals Recombinant Human Endostatin Global Market Share (2011-2016)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Acceleron Pharma Recombinant Human Endostatin Global Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biocon Recombinant Human Endostatin Global Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bionomics Recombinant Human Endostatin Global Market Share (2011-2016)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CASI Pharmaceuticals Recombinant Human Endostatin Global Market Share (2011-2016)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Corporation Recombinant Human Endostatin Global Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Enzon Pharmaceuticals Recombinant Human Endostatin Global Market Share (2011-2016)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Five Prime Therapeutics Recombinant Human Endostatin Global Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Global Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Recombinant Human Endostatin Global Market Share (2011-2016)
Table Genexine Basic Information List
Table Genexine Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genexine Recombinant Human Endostatin Global Market Share (2011-2016)
Table Hetero Drugs Basic Information List
Table Hetero Drugs Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hetero Drugs Recombinant Human Endostatin Global Market Share (2011-2016)
Table ImClone Systems Basic Information List
Table ImClone Systems Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ImClone Systems Recombinant Human Endostatin Global Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Intas Pharmaceuticals Recombinant Human Endostatin Global Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Kyowa Hakko Kirin Recombinant Human Endostatin Global Market Share (2011-2016)
Table Levolta Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Levolta Pharmaceuticals Recombinant Human Endostatin Global Market Share (2011-2016)
Table Mabtech Basic Information List
Table Mabtech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mabtech Recombinant Human Endostatin Global Market Share (2011-2016)
Table Marsala Biotech Basic Information List
Table Marsala Biotech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Marsala Biotech Recombinant Human Endostatin Global Market Share (2011-2016)
Table Neumedicines Basic Information List
Table Neumedicines Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Neumedicines Recombinant Human Endostatin Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Recombinant Human Endostatin Global Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Oncobiologics Recombinant Human Endostatin Global Market Share (2011-2016)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Onyx Pharmaceuticals Recombinant Human Endostatin Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Endostatin
Figure Manufacturing Process Analysis of Recombinant Human Endostatin
Figure Recombinant Human Endostatin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Endostatin
Table Distributors/Traders List
Figure Global Recombinant Human Endostatin Sales and Growth Rate Forecast (2016-2021)
Figure Global Recombinant Human Endostatin Revenue and Growth Rate Forecast (2016-2021)
Table Global Recombinant Human Endostatin Sales Forecast by Regions (2016-2021)
Table Global Recombinant Human Endostatin Sales Forecast by Type (2016-2021)
Table Global Recombinant Human Endostatin Sales Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • United States Tumor Marker Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 96
    Notes: Sales, means the sales volume of Tumor Marker Revenue, means the sales value of Tumor Marker This report studies sales (consumption) of Tumor Marker in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abbott - Siemens - Alere - Johnson - BD - Nova - ... Market Segment by States, covering - California - Texas......
  • United States Mildronate Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Mildronate Revenue, means the sales value of Mildronate This report studies sales (consumption) of Mildronate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Psypharm - Latvian company - Jinan Chenghui-shuangda Chemical - Canadian Pharmacy - Grindex company - Slovakia - United Pharmacies - chemBli......
  • United States Argatroban Powder Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 116
    Notes: Sales, means the sales volume of Argatroban Powder Revenue, means the sales value of Argatroban Powder This report studies sales (consumption) of Argatroban Powder in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Pfizer, Inc - SANDOZ - GlaxoSmithKline Plc - fresenius-kabi - Eagle Pharmaceuticals, Inc - Mitsubishi Tanabe Pharma - Teva Ph......
  • Global Nonalcoholic Steatohepatitis (NASH) Sales Market Report 2017
    Published: 22-Feb-2017        Price: US 4000 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Nonalcoholic Steatohepatitis (NASH) Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH) This report studies sales (consumption) of Nonalcoholic Steatohepatitis (NASH) in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Boehringer Ingelheim?......
  • Global Finasteride Sales Market Report 2017
    Published: 22-Feb-2017        Price: US 4000 Onwards        Pages: 113
    Notes: Sales, means the sales volume of Finasteride Revenue, means the sales value of Finasteride This report studies sales (consumption) of Finasteride in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Merck - Actavis - Sandoz - Teva Pharmaceuticals - Cipla - RelonC......
  • China HIV Drugs Market Research Report 2017
    Published: 21-Feb-2017        Price: US 3200 Onwards        Pages: 116
    Notes: Sales, means the sales volume of HIV Drugs Revenue, means the sales value of HIV Drugs This report studies HIV Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Bristol-Myers Squibb - Gilead Sciences - GSK - Johnson - Merck - AbbVie - AstraZeneca - Boehringer Ingelheim - Cipla - Daii......
  • China Medicinal Vaseline Market Research Report 2017
    Published: 21-Feb-2017        Price: US 3200 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Medicinal Vaseline Revenue, means the sales value of Medicinal Vaseline This report studies Medicinal Vaseline in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Company 1 - Company 2 - Company 3 - Company 4 - Company 5 - Company 6 - Company 7 - Company 8 - Company......
  • Europe Trazodone Market Report 2017
    Published: 21-Feb-2017        Price: US 3900 Onwards        Pages: 124
    Notes: Sales, means the sales volume of Trazodone Revenue, means the sales value of Trazodone This report studies sales (consumption) of Trazodone in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Teva - Angelini - Mylan - Fermion - The Piramal Group ......
  • Europe Tranylcypromine Market Report 2017
    Published: 21-Feb-2017        Price: US 3900 Onwards        Pages: 127
    Notes: Sales, means the sales volume of Tranylcypromine Revenue, means the sales value of Tranylcypromine This report studies sales (consumption) of Tranylcypromine in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Teva - Emcure - Novartis - Mylan -......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs